Copeptin Serum Level in Liver Transplant Recipients
Sponsor
Medical University of Warsaw (Other)
Overall Status
Completed
CT.gov ID
NCT03587623
Collaborator
(none)
38
1
18.9
2
Study Details
Study Description
Brief Summary
The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
38 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Copeptin Serum Level in Liver Transplant Recipients
Actual Study Start Date
:
Jul 4, 2018
Actual Primary Completion Date
:
Jan 31, 2020
Actual Study Completion Date
:
Jan 31, 2020
Outcome Measures
Primary Outcome Measures
- Serum Copeptin concentration [Baseline, intraoperatively, 1,3,7,21 day postoperatively]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patient undergoing liver transplantation
Exclusion Criteria:
-
Serum creatinine > 1,5 mg/dl
-
Retransplantation
-
Patient refusal
-
CRRT or dialysis preoperatively
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | I Klinika Anestezjologii WUM | Warsaw | Mazovian Voivodeship | Poland | 02-005 |
Sponsors and Collaborators
- Medical University of Warsaw
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Beata Błaszczyk,
Principal Investigator,
Medical University of Warsaw
ClinicalTrials.gov Identifier:
NCT03587623
Other Study ID Numbers:
- Livercopeptin
First Posted:
Jul 16, 2018
Last Update Posted:
Aug 19, 2020
Last Verified:
Aug 1, 2020